The stock of Petmed Express Inc (NASDAQ:PETS) hit a new 52-week high and has $41.52 target or 95.00% above today’s $21.29 share price. The 9 months bullish chart indicates low risk for the $454.83M company. The 1-year high was reported on Nov, 11 by Barchart.com. If the $41.52 price target is reached, the company will be worth $432.09M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock increased 3.00% or $0.62 during the last trading session, hitting $21.29. About 292,358 shares traded hands or 48.40% up from the average. Petmed Express Inc (NASDAQ:PETS) has risen 18.32% since April 11, 2016 and is uptrending. It has outperformed by 12.17% the S&P500.
Petmed Express Inc (NASDAQ:PETS) Ratings Coverage
Out of 2 analysts covering Petmed Express Inc (NASDAQ:PETS), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Petmed Express Inc has been the topic of 2 analyst reports since February 4, 2016 according to StockzIntelligence Inc. The stock of Petmed Express Inc (NASDAQ:PETS) earned “Underperform” rating by Credit Suisse on Thursday, February 4. Craig Hallum upgraded the shares of PETS in a report on Monday, May 9 to “Hold” rating.
According to Zacks Investment Research, “Petmed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.”
Insitutional Activity: The institutional sentiment decreased to 0.88 in 2016 Q2. Its down 0.31, from 1.19 in 2016Q1. The ratio worsened, as 17 funds sold all Petmed Express Inc shares owned while 51 reduced positions. 19 funds bought stakes while 41 increased positions. They now own 14.80 million shares or 6.13% less from 15.76 million shares in 2016Q1.
Diversified Inv Strategies Ltd, a Louisiana-based fund reported 87,025 shares. Pinebridge Limited Partnership, a New York-based fund reported 2,367 shares. Moreover, Nationwide Fund Advisors has 0% invested in Petmed Express Inc (NASDAQ:PETS) for 12,880 shares. Northern Tru Corporation owns 268,653 shares or 0% of their US portfolio. Loomis Sayles And Limited Partnership has 0% invested in the company for 165 shares. The Delaware-based Blackrock Advisors Limited Liability Corp has invested 0% in Petmed Express Inc (NASDAQ:PETS). Moreover, Bancshares Of Montreal Can has 0% invested in Petmed Express Inc (NASDAQ:PETS) for 7,647 shares. Pnc Financial Ser Gp last reported 0% of its portfolio in the stock. Dimensional Fund Advisors Ltd Partnership accumulated 518,199 shares or 0.01% of the stock. Sector Pension Invest Board holds 0% of its portfolio in Petmed Express Inc (NASDAQ:PETS) for 13,992 shares. Citadel Advisors Ltd has 0% invested in the company for 31,979 shares. Amp Invsts Ltd has invested 0% of its portfolio in Petmed Express Inc (NASDAQ:PETS). Tower Research Cap Limited Company (Trc) holds 0% of its portfolio in Petmed Express Inc (NASDAQ:PETS) for 1,372 shares. Ls Investment Ltd Liability Corp has invested 0% of its portfolio in Petmed Express Inc (NASDAQ:PETS). Blue Fincl Capital accumulated 12,755 shares or 0.2% of the stock.
Insider Transactions: Since August 8, 2016, the stock had 0 insider purchases, and 6 selling transactions for $766,150 net activity. SCHWEITZER ROBERT C also sold $92,355 worth of Petmed Express Inc (NASDAQ:PETS) shares. AKDAG MENDERES also sold $207,500 worth of Petmed Express Inc (NASDAQ:PETS) shares. 1,500 Petmed Express Inc (NASDAQ:PETS) shares with value of $31,500 were sold by ROSENBLOOM BRUCE S.
More important recent Petmed Express Inc (NASDAQ:PETS) news were published by: Quotes.Wsj.com which released: “News PetMed Express Inc.PETS” on February 12, 2011, also Nasdaq.com published article titled: “Earnings Reaction History: PetMed Express, Inc., 25.0% Follow-Through …”, Nasdaq.com published: “PetMed Express, Inc. (PETS) Ex-Dividend Date Scheduled for November 03, 2016” on November 02, 2016. More interesting news about Petmed Express Inc (NASDAQ:PETS) was released by: Nasdaq.com and their article: “PetMed Express Inc. Reports 9% Advance In Q2 Bottom Line” with publication date: October 24, 2016.
PETS Company Profile
PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, incorporated on January 3, 1997, is a pet pharmacy. The Firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Firm offers a selection of products for dogs and cats. The Company’s product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.